Absorbent article with urease inhibitor and use of the article
AssigneeThe Procter & Gamble Company
InventorsBruno Johannes EHRNSPERGER, Deepika Dayal MATHUR, Aniruddha CHATTERJEE, Mattias SCHMIDT, Juliane KAMPHUS
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of a urease inhibitor in an absorbent article to maintain the pH of the wearer's skin in a range of 4.0 to 6.0, wherein the urease inhibitor is provided between the topsheet and the absorbent core and/or is provided in the absorbent core. The invention also relates to absorbent articles comprising a urease inhibitor.
Claims23
An absorbent article comprising a liquid permeable topsheet, a liquid impermeable backsheet, an absorbent core disposed between the topsheet and the backsheet, and a urease inhibitor;
- wherein the urease inhibitor is disposed between the topsheet and the absorbent core and/or within the absorbent core;
- and wherein the absorbent article is configured to maintain a pH of a wearer's skin in a range of about 4.0 to about 6.0 according to the Urease Activity test method.
An absorbent article comprising a liquid permeable topsheet, a liquid impermeable backsheet, an absorbent core disposed between the topsheet and the backsheet, and a urease inhibitor,
- wherein the urease inhibitor is disposed between the topsheet and the absorbent core and/or in the absorbent core,
- wherein the absorbent article has a longitudinal centerline and a longitudinal dimension extending along the longitudinal centerline, and a transverse centerline extending perpendicular to the longitudinal centerline,
- the absorbent article comprising a front waist region with a front waist edge, a back waist region with a back waist edge, and a crotch region longitudinally extending between the front waist region and the back waist region, wherein each of the front waist region, the back waist region, and the crotch region forms one third of the longitudinal dimension, and
- wherein an amount of the urease inhibitor disposed in the crotch region is greater than an amount of the urease inhibitor disposed in the back waist region.
Dependencies are inferred from the claim text.